William Mattes

Strategic paths for biomarker qualification.

Federico M Goodsaid, Felix W Frueh, William Mattes, 2008, Toxicology.

Molecular Docking for Identification of Potential Targets for Drug Repurposing.

Heng Luo, Huixiao Hong, William Mattes, 2016, Current topics in medicinal chemistry.

Towards consensus practices to qualify safety biomarkers for use in early drug development

Frank D Sistare, Elizabeth Walker, Peter Kasper, 2010, Nature Biotechnology.

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Krishna Prasad, Peter Kasper, Jonathan A Phillips, 2010, Nature Biotechnology.

The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical Path.

Felix W Frueh, William Mattes, F. Frueh, 2007, Drug discovery today. Technologies.

Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysis

Weida Tong, Huixiao Hong, Leming Shi, 2015, BMC Bioinformatics.

microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment.

Huixiao Hong, Si Chen, Lei Guo, 2015, Biomarkers in medicine.

Biomarkers of tobacco smoke exposure.

William Mattes, Xi Yang, Donna L Mendrick, 2014, Advances in clinical chemistry.